Lawmakers explore using opioid settlement money to study the drug ibogaine
A high-ranking lawmaker is asking Mississippi to use $5 million of opioid settlement money to explore the medical potential of ibogaine, a drug with mixed evidence of its ability to safely treat addiction. At a meeting Thursday of the House and Senate committees that deal with public health, Republican Rep. Sam Creekmore of New Albany […]
UnitedHealth, Amedisys settle with Illinois, DOJ over $3.3 billion merger
UnitedHealth and Amedisys have agreed to a settlement with Illinois, three states and the Department of Justice, clearing the path for their $3.3 billion merger to go through.
Mississippi opioid settlement council finalizes grant applications
Mississippi’s Opioid Settlement Fund Advisory Council has finalized and expects to soon release grant applications for the tens of millions of dollars it oversees, moving the state closer to using its settlement money to address addiction. The council held a make-up meeting in Jackson late Friday afternoon after a virtual session was derailed by hackers […]
Illinois to receive over $925,000 in settlement with Gilead Sciences over kickbacks to providers for prescriptions
Illinois will receive over $925,000 as part of a multistate settlement in principle with Gilead Sciences for allegedly running an illegal kickback scheme to promote their HIV medications, Attorney General Kwame Raoul said Wednesday.
Illinois slated to receive nearly $149 million in Purdue Pharma, Sacklers settlement
Illinois is expected to receive nearly $149 million as part of the national $7.4 billion settlement with Purdue Pharma, the maker of Oxycontin, and its owners over their improper marketing of opioids, Attorney General Kwame Raoul said this week.
Opinion | ‘Can’t Just Sit Back and Walk Away With a Settlement’: What We Heard This Week
“I can’t just sit back and walk away with a settlement.” — Ming Lin, MD, an emergency medicine physician who was fired early in the COVID pandemic for airing alleged safety concerns. “This is getting at the whole diagnostic odyssey for rare diseases.” — P.J. Brooks, PhD, acting director of NIH’s NCATS’ Division of Rare […]